More Than 200 Patient Advocates, Healthcare Entities, Companies Urge Finalized Pharmacy DIR Fee Transparency Rule That Would Promote Patient Access, Protect Pharmacy Viability Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”

2022-03-11T16:31:23-05:00Categories: Press Release|Tags: , , , , |

Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”.

NACDS Expresses Support for CMS’ Pharmacy DIR Fee Transparency Proposal, Urges Additional Actions to Achieve Comprehensive Pharmacy DIR Reform, Protect Patients’ Access to Care NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.

2022-03-07T16:52:36-05:00Categories: Press Release|Tags: , , , , |

NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.

NACDS Honored with Chain Drug Review’s “Retailer of the Year” Award The recognition is a powerful tribute to the diverse membership that comprises NACDS and their commitment to serving the American people

2022-01-13T11:04:19-05:00Categories: Press Release|Tags: , , , , , |

The recognition is a powerful tribute to the diverse membership that comprises NACDS and their commitment to serving the American people.

NACDS Emphasizes Members’ Contributions to Fight Against the COVID Pandemic and Vision for a Future of Service in U.S. Chamber of Commerce Report Pharmacies have proven themselves again throughout the pandemic as the face of neighborhood healthcare with “lights on, doors open” every step of the way

2022-01-12T09:39:24-05:00Categories: Press Release|Tags: , , , |

Pharmacies have proven themselves again throughout the pandemic as the face of neighborhood healthcare with “lights on, doors open” every step of the way.

NACDS Welcomes Biden Administration’s Action to Confront Dire “DIR Fees” That Inflate Seniors’ Drug Costs and Jeopardize Pharmacies’ Viability NACDS to prepare recommendations to maximize this historic opportunity to reduce seniors’ out-of-pocket drug costs and to help preserve critical, convenient and equitable pharmacy access

2022-01-07T10:28:05-05:00Categories: Press Release|Tags: , , |

NACDS to prepare recommendations to maximize this historic opportunity to reduce seniors’ out-of-pocket drug costs and to help preserve critical, convenient and equitable pharmacy access.

NACDS Applauds Eighth Circuit Decision Upholding North Dakota Law Regulating PBMs Court reinforces and strengthens landmark U.S. Supreme Court ruling in pivotal Rutledge case

2021-11-18T13:31:33-05:00Categories: Press Release|Tags: , , , |

NACDS is hailing a decision by the Eighth Circuit of the U.S. Court of Appeals yesterday which upholds a North Dakota law prioritizing the health and safety of patients by promoting the economic viability of local pharmacies.

An “Obvious Miss” for Seniors’ Drug Savings: NACDS Hits Lack of Pharmacy DIR Fee Reform in Current Budget Reconciliation Bill

2021-11-10T10:57:15-05:00Categories: Press Release|Tags: , , , , |

NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.

Go to Top